124 related articles for article (PubMed ID: 30789501)
1. Distinct Histologic, Immunohistochemical and Clinical Features Associated With Serous Endometrial Intraepithelial Carcinoma Involving Polyps.
Trinh VQ; Pelletier MP; Echelard P; Warkus T; Sauthier P; Gougeon F; Mès-Masson AM; Provencher DM; Rahimi K
Int J Gynecol Pathol; 2020 Mar; 39(2):128-135. PubMed ID: 30789501
[TBL] [Abstract][Full Text] [Related]
2. Metachronous serous endometrial intraepithelial carcinoma and serous peritoneal carcinoma: analysis of probable independent lesions.
Furuya M; Sato T; Tanaka R; Yamamoto M; Yokota NR; Miyagi E
Diagn Pathol; 2016 Nov; 11(1):130. PubMed ID: 27842566
[TBL] [Abstract][Full Text] [Related]
3. HER-2 Amplification in Uterine Serous Carcinoma and Serous Endometrial Intraepithelial Carcinoma.
Banet N; Shahi M; Batista D; Yonescu R; Tanner EJ; Fader AN; Cimino-Mathews A
Am J Surg Pathol; 2021 May; 45(5):708-715. PubMed ID: 33739786
[TBL] [Abstract][Full Text] [Related]
4. Serous endometrial intraepithelial carcinoma: A clinico-pathological study of 48 cases and its association with endometrial polyps - A tertiary care oncology centre experience.
Yadav S; Agarwal A; Mokal S; Menon S; Rekhi B; Deodhar K
Eur J Obstet Gynecol Reprod Biol; 2021 Sep; 264():168-172. PubMed ID: 34304025
[TBL] [Abstract][Full Text] [Related]
5. Serous endometrial intraepithelial carcinoma (SEIC): Current clinical practice in The Netherlands.
Slaager C; Hofhuis W; Hoogduin K; Ewing-Graham P; van Beekhuizen H
Eur J Obstet Gynecol Reprod Biol; 2021 Oct; 265():25-29. PubMed ID: 34416579
[TBL] [Abstract][Full Text] [Related]
6. Uterine superficial serous carcinomas and extensive serous endometrial intraepithelial carcinomas: clinicopathological analysis of 6 patients.
Ono K; Hayashi H; Tateno M; Tanaka R; Suzuki R; Maruyama Y; Miyagi Y; Furuya M
Int J Clin Exp Pathol; 2014; 7(11):7979-88. PubMed ID: 25550841
[TBL] [Abstract][Full Text] [Related]
7. A case of synchronous serous ovarian cancer and uterine serous endometrial intraepithelial carcinoma.
Shimizu M; Yamanaka K; Azumi M; Tomimoto M; Washio K; Takahashi R; Nagamata S; Murata Y; Yamasaki Y; Terai Y
J Ovarian Res; 2021 Jun; 14(1):87. PubMed ID: 34187525
[TBL] [Abstract][Full Text] [Related]
8. Evidence for a latent precursor (p53 signature) that may precede serous endometrial intraepithelial carcinoma.
Jarboe EA; Pizer ES; Miron A; Monte N; Mutter GL; Crum CP
Mod Pathol; 2009 Mar; 22(3):345-50. PubMed ID: 19151662
[TBL] [Abstract][Full Text] [Related]
9. Immunophenotypic Analysis in Early Müllerian Serous Carcinogenesis.
Nafisi H; Ghorab Z; Ismill N; Dubé V; Plotkin A; Han G; Cesari M; Lu FI; Saad R; Khalifa M; Nofech-Mozes S
Int J Gynecol Pathol; 2015 Sep; 34(5):424-36. PubMed ID: 26107560
[TBL] [Abstract][Full Text] [Related]
10. Serous endometrial cancers that mimic endometrioid adenocarcinomas: a clinicopathologic and immunohistochemical study of a group of problematic cases.
Darvishian F; Hummer AJ; Thaler HT; Bhargava R; Linkov I; Asher M; Soslow RA
Am J Surg Pathol; 2004 Dec; 28(12):1568-78. PubMed ID: 15577675
[TBL] [Abstract][Full Text] [Related]
11. Nrf2 expression in endometrial serous carcinomas and its precancers.
Chen N; Yi X; Abushahin N; Pang S; Zhang D; Kong B; Zheng W
Int J Clin Exp Pathol; 2010 Dec; 4(1):85-96. PubMed ID: 21228930
[TBL] [Abstract][Full Text] [Related]
12. The oncofetal protein IMP3: a novel biomarker for endometrial serous carcinoma.
Zheng W; Yi X; Fadare O; Liang SX; Martel M; Schwartz PE; Jiang Z
Am J Surg Pathol; 2008 Feb; 32(2):304-15. PubMed ID: 18223334
[TBL] [Abstract][Full Text] [Related]
13. Primary sources of pelvic serous cancer in patients with endometrial intraepithelial carcinoma.
Jia L; Yuan Z; Wang Y; Cragun JM; Kong B; Zheng W
Mod Pathol; 2015 Jan; 28(1):118-27. PubMed ID: 24925054
[TBL] [Abstract][Full Text] [Related]
14. Concurrent endometrial intraepithelial carcinoma (EIC) and serous ovarian cancer: can EIC be seen as the precursor lesion?
Roelofsen T; van Kempen LC; van der Laak JA; van Ham MA; Bulten J; Massuger LF
Int J Gynecol Cancer; 2012 Mar; 22(3):457-64. PubMed ID: 22249577
[TBL] [Abstract][Full Text] [Related]
15. Endometrial Serous Carcinoma With Clear-Cell Change: Frequency and Immunohistochemical Analysis.
Hariri N; Qarmali M; Fadare O
Int J Surg Pathol; 2018 Apr; 26(2):126-134. PubMed ID: 28954565
[TBL] [Abstract][Full Text] [Related]
16. Stromal p16 expression is significantly increased in endometrial carcinoma.
Yoon G; Koh CW; Yoon N; Kim JY; Kim HS
Oncotarget; 2017 Jan; 8(3):4826-4836. PubMed ID: 27902476
[TBL] [Abstract][Full Text] [Related]
17. Clear cell carcinoma of the endometrium is characterized by a distinctive profile of p53, Ki-67, estrogen, and progesterone receptor expression.
Lax SF; Pizer ES; Ronnett BM; Kurman RJ
Hum Pathol; 1998 Jun; 29(6):551-8. PubMed ID: 9635673
[TBL] [Abstract][Full Text] [Related]
18. Mixed endometrial carcinomas with a "low-grade serous"-like component: a clinicopathologic, immunohistochemical, and molecular genetic study.
Espinosa I; D'Angelo E; Corominas M; Gonzalez A; Prat J
Hum Pathol; 2018 Jan; 71():65-73. PubMed ID: 29079180
[TBL] [Abstract][Full Text] [Related]
19. Differential expression of WT1 and p53 in serous and endometrioid carcinomas of the endometrium.
Egan JA; Ionescu MC; Eapen E; Jones JG; Marshall DS
Int J Gynecol Pathol; 2004 Apr; 23(2):119-22. PubMed ID: 15084839
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical loss of BRCA1 protein in uterine serous carcinoma.
Hecht JL; Konstantinopoulos PA; Awtrey CS; Soslow RA
Int J Gynecol Pathol; 2014 May; 33(3):282-7. PubMed ID: 24681740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
